Epidemic SI COVID-19 modeling in LMICs: accompanying commentary by Pan-ngum, W, Clapham, H, Dawa, J, Pulliam, JRC

The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing intensive care unit capacity by Nichols, BE, Jamieson, L, Zhang, SRC, Rao, GA, Silal, S, Pulliam, JRC, Sanne, I, Meyer-Rath, G

The National COVID-19 Epi Model (NCEM): estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa by Silal, SP, Pulliam, JRC, Meyer-Rath, G, Jamieson, L, Nichols, BE, Norman, J, Hounsell, R, Mayet, S, Kagoro, F, Moultrie, H

Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa by Jo, Y, Jamieson, L, Edoka, I, Long, L, Silal, S, Pulliam, JRC, Moultrie, H, Sanne, I, Meyer-Rath, G, Nichols, BE

Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa by Silal, SP, Groome, MJ, Govender, N, Pulliam, JRC, Ramadan, OP, Puren, A, Jassat, W, Leonard, E, Moultrie, H, Meyer-Rath, KG, Ramkrishna, W, Langa, T, Furumele, T, Moonasar, D, Cohen, C, Walaza, S

Key questions for modelling COVID-19 exit strategies by Thompson, RN, Hollingsworth, TD, Isham, V, Arribas-Bel, D, Ashby, B, Britton, T, Challoner, P, Chappell, LHK, Clapham, H, Cunniffe, NJ, Dawid, AP, Donnelly, CA, Eggo, R, Funk, S, Gilbert, N, Glendinning, P, Gog, JR, Hart, WS, Heesterbeek, H, House, T, Keeling, M, Kiss, IZ, Kretzschmar, M, Lloyd, AL, McBryde, ES, McCaw, JM, McKinley, TJ, Miller, JC, Morris, M, ONeill, PD, Parag, KV, Pearson, CAB, Pellis, L, Pulliam, JRC, Ross, JV, Tomba, GS, Silverman, BW, Struchiner, CJ, Tildesley, MJ, Trapman, P, Webb, CR, Mollison, D, Restif, O